| Epidemiology of neuromyelitis optica in the United States: a multicenter analysis MA Mealy, DM Wingerchuk, BM Greenberg, M Levy Archives of neurology 69 (9), 1176-1180, 2012 | 357 | 2012 |
| Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy MA Mealy, DM Wingerchuk, J Palace, BM Greenberg, M Levy JAMA neurology 71 (3), 324-330, 2014 | 328 | 2014 |
| Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange H Abboud, A Petrak, M Mealy, S Sasidharan, L Siddique, M Levy Multiple Sclerosis Journal 22 (2), 185-192, 2016 | 256 | 2016 |
| MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder R Narayan, A Simpson, K Fritsche, S Salama, S Pardo, M Mealy, F Paul, ... Multiple sclerosis and related disorders 25, 66-72, 2018 | 210 | 2018 |
| Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients L Kremer, M Mealy, A Jacob, I Nakashima, P Cabre, S Bigi, F Paul, ... Multiple Sclerosis Journal 20 (7), 843-847, 2014 | 202 | 2014 |
| Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic RA Kessler, MA Mealy, M Levy Current treatment options in neurology 18, 1-15, 2016 | 161 | 2016 |
| Racial differences in neuromyelitis optica spectrum disorder SH Kim, MA Mealy, M Levy, F Schmidt, K Ruprecht, F Paul, M Ringelstein, ... Neurology 91 (22), e2089-e2099, 2018 | 157 | 2018 |
| In vivo identification of morphologic retinal abnormalities in neuromyelitis optica ES Sotirchos, S Saidha, G Byraiah, MA Mealy, MA Ibrahim, YJ Sepah, ... Neurology 80 (15), 1406-1414, 2013 | 142 | 2013 |
| Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging Y Pekcevik, CH Mitchell, MA Mealy, G Orman, IH Lee, SD Newsome, ... Multiple Sclerosis Journal 22 (3), 302-311, 2016 | 130 | 2016 |
| Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder VS Chavarro, MA Mealy, A Simpson, A Lacheta, F Pache, K Ruprecht, ... Neurology: Neuroimmunology & Neuroinflammation 3 (6), e286, 2016 | 111 | 2016 |
| Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker O Aktas, MA Smith, WA Rees, JL Bennett, D She, E Katz, BAC Cree, ... Annals of neurology 89 (5), 895-910, 2021 | 97 | 2021 |
| Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis MA Mealy, A Whetstone, G Orman, I Izbudak, PA Calabresi, M Levy Journal of the neurological sciences 355 (1-2), 59-63, 2015 | 97 | 2015 |
| Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion … ES Sotirchos, A Filippatou, KC Fitzgerald, S Salama, S Pardo, J Wang, ... Multiple Sclerosis Journal 26 (11), 1360-1371, 2020 | 93 | 2020 |
| Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy P Barreras, KC Fitzgerald, MA Mealy, JA Jimenez, D Becker, ... Neurology 90 (1), e12-e21, 2018 | 87 | 2018 |
| Mortality in neuromyelitis optica is strongly associated with African ancestry MA Mealy, RA Kessler, Z Rimler, A Reid, L Totonis, G Cutter, I Kister, ... Neurology: Neuroimmunology & Neuroinflammation 5 (4), e468, 2018 | 85 | 2018 |
| Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica M Levy, MA Mealy Neuroimmunology & Neuroinflammation 1 (1), e5, 2014 | 79 | 2014 |
| High risk of postpartum relapses in neuromyelitis optica spectrum disorder EC Klawiter, R Bove, L Elsone, E Alvarez, N Borisow, M Cortez, F Mateen, ... Neurology 89 (22), 2238-2244, 2017 | 70 | 2017 |
| Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion … MA Mealy, SE Mossburg, SH Kim, S Messina, N Borisow, ... Multiple sclerosis and related disorders 28, 64-68, 2019 | 59 | 2019 |
| Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community S Eaneff, V Wang, M Hanger, M Levy, MA Mealy, AU Brandt, D Eek, ... Multiple sclerosis and related disorders 17, 116-122, 2017 | 58 | 2017 |
| Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders MA Mealy, SH Kim, F Schmidt, R López, JA Jimenez Arango, F Paul, ... Multiple Sclerosis Journal 24 (13), 1737-1742, 2018 | 53 | 2018 |
Michael Levy, MD, PhDMassachusetts General Hospital and Harvard Medical School在 mgh.harvard.edu 的电子邮件经过验证
